Correlation Between Genovate Biotechnology and SciVision Biotech
Can any of the company-specific risk be diversified away by investing in both Genovate Biotechnology and SciVision Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genovate Biotechnology and SciVision Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genovate Biotechnology Co and SciVision Biotech, you can compare the effects of market volatilities on Genovate Biotechnology and SciVision Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genovate Biotechnology with a short position of SciVision Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genovate Biotechnology and SciVision Biotech.
Diversification Opportunities for Genovate Biotechnology and SciVision Biotech
0.53 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Genovate and SciVision is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Genovate Biotechnology Co and SciVision Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SciVision Biotech and Genovate Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genovate Biotechnology Co are associated (or correlated) with SciVision Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SciVision Biotech has no effect on the direction of Genovate Biotechnology i.e., Genovate Biotechnology and SciVision Biotech go up and down completely randomly.
Pair Corralation between Genovate Biotechnology and SciVision Biotech
Assuming the 90 days trading horizon Genovate Biotechnology is expected to generate 2.17 times less return on investment than SciVision Biotech. In addition to that, Genovate Biotechnology is 2.17 times more volatile than SciVision Biotech. It trades about 0.02 of its total potential returns per unit of risk. SciVision Biotech is currently generating about 0.08 per unit of volatility. If you would invest 5,731 in SciVision Biotech on October 30, 2024 and sell it today you would earn a total of 6,569 from holding SciVision Biotech or generate 114.62% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 99.79% |
| Values | Daily Returns |
Genovate Biotechnology Co vs. SciVision Biotech
Performance |
| Timeline |
| Genovate Biotechnology |
| SciVision Biotech |
Genovate Biotechnology and SciVision Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Genovate Biotechnology and SciVision Biotech
The main advantage of trading using opposite Genovate Biotechnology and SciVision Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genovate Biotechnology position performs unexpectedly, SciVision Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SciVision Biotech will offset losses from the drop in SciVision Biotech's long position.| Genovate Biotechnology vs. Realtek Semiconductor Corp | Genovate Biotechnology vs. Simple Mart Retail | Genovate Biotechnology vs. Niko Semiconductor Co | Genovate Biotechnology vs. Syntek Semiconductor Co |
| SciVision Biotech vs. Maxigen Biotech | SciVision Biotech vs. Chunghwa Chemical Synthesis | SciVision Biotech vs. Sinphar Pharmaceutical Co | SciVision Biotech vs. ScinoPharm Taiwan |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |